BIIB - Biogen Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2019-12-30
2018-12-30
2017-12-30
2016-12-30
Total Revenue
14,377,900
-
13,452,900
12,273,900
11,448,800
Cost of Revenue
1,955,400
-
1,816,300
1,630,000
1,478,700
Gross Profit
12,422,500
-
11,636,600
10,643,900
9,970,100
Operating Expenses
Research Development
2,280,600
-
2,597,200
2,253,600
1,973,300
Selling General and Administrative
2,374,700
-
2,106,300
1,935,500
1,947,900
Total Operating Expenses
5,386,800
-
5,635,800
5,116,100
4,317,000
Operating Income or Loss
7,035,700
-
6,000,800
5,527,800
5,653,100
Interest Expense
187,400
-
200,600
250,800
260,000
Total Other Income/Expenses Net
157,600
-
-13,100
-226,700
-523,500
Income Before Tax
7,125,900
-
5,899,600
5,128,800
4,933,000
Income Tax Expense
1,158,000
-
1,425,600
2,458,700
1,237,300
Income from Continuing Operations
5,888,500
-
4,474,000
2,670,100
3,695,700
Net Income
5,888,500
-
4,430,700
2,539,100
3,702,800
Net Income available to common shareholders
5,888,500
-
4,430,700
2,539,100
3,702,800
Reported EPS
Basic
-
31.47
21.63
11.94
16.96
Diluted
-
31.42
21.58
11.92
16.93
Weighted average shares outstanding
Basic
-
187,100
204,900
212,600
218,400
Diluted
-
187,400
205,300
213,000
218,800
EBITDA
-
-
7,116,800
6,460,600
5,875,700